COL6A2 drives clear cell renal cell carcinoma progression via integrin-dependent modulation of Wnt/β-catenin signaling
Journal of Cancer · 2025-11-14 · 16 (15) · 4426-4439
DOI: 10.7150/jca.120607 ↗At a glance
Journal article in Journal of Cancer, published on 2025-11-14. Written by Xing Ji and 6 co-authors. Institution: Department of Urology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China. Cited 2 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Abstract non disponibile.
Subjects
Author keywords
Authors and institutions
- Department of Urology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
- Department of Urology, Peking University First Hospital, Beijing, 100034, China.
- Institution of Urology, Peking University, Beijing, 100034, China.
- National Urological Cancer Center, Beijing, 100034, China.
- Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, 100034, China.
Cite
APA
Ji, X., Yun, Y., Zhu, Z., Wu, T., Ruan, M., Fan, Y., & Zhang, Q. (2025). COL6A2 drives clear cell renal cell carcinoma progression via integrin-dependent modulation of Wnt/β-catenin signaling. Journal of Cancer, 16(15), 4426-4439. https://doi.org/10.7150/jca.120607
Vancouver
Ji X, Yun Y, Zhu Z, Wu T, Ruan M, Fan Y, et al. COL6A2 drives clear cell renal cell carcinoma progression via integrin-dependent modulation of Wnt/β-catenin signaling. Journal of Cancer. 2025;16(15):4426-4439. doi:10.7150/jca.120607
BibTeX
@article{Ji2025,
author = {Ji, Xing and Yun, Yongyang and Zhu, Zhenpeng and Wu, Tianyu and Ruan, Mingjian and Fan, Yu and Zhang, Qian},
title = {COL6A2 drives clear cell renal cell carcinoma progression via integrin-dependent modulation of Wnt/β-catenin signaling},
journal = {Journal of Cancer},
year = {2025},
volume = {16},
number = {15},
pages = {4426--4439},
doi = {10.7150/jca.120607}
}
EUVIMED